Persantine
Drug - Persantine
The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
The product dosage form and route separated by a semi-colon.
Active Ingredient(s) -
Dipyridamole
Multiple ingredients are in alphabetical order.
Strength -
25MG
The potency of the active ingredient(s), Dipyridamole. May repeat for multiple part products.
Applicant -
BOEHRINGER INGELHEIM
The firm name holding legal responsibility for Persantine. The firm name is condensed to a maximum twenty character unique string.
New Drug Application (NDA) Number -
012836
The FDA assigned number to Persantine. Format is nnnnnn.
Product Number -
003
The FDA assigned number to identify Persantine. Each strength is a separate product. May repeat for multiple part products. Format is nnn.
Therapeutic Equivalence (TE) Code -
AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.
Approval Date -
Dec 22, 1986
The date Persantine was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".
Reference Listed Drug (RLD) -
No
The pioneer or innovator of Persantine. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.
Type -
RX
The group or category of approved drugs Persantine is in. Format is RX, OTC, DISCN.
Applicant Full Name -
Boehringer Ingelheim Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Persantine.
Persantine
|
